Sponsored
Sponsored
Media Summary: Moderated by Jennifer Farmer, Chief Executive Officer, FARA Representatives from: Biogen, Design Therapeutics, Larimar ... In this episode of AD/PD™ Session Spotlight, we present Plenary Lecture 1 from AD/PD™ Research Spotlight on Andrew Siderowf, MD, MS.

2025 Annual Drug Development Update - Detailed Analysis & Overview

Moderated by Jennifer Farmer, Chief Executive Officer, FARA Representatives from: Biogen, Design Therapeutics, Larimar ... In this episode of AD/PD™ Session Spotlight, we present Plenary Lecture 1 from AD/PD™ Research Spotlight on Andrew Siderowf, MD, MS. Progress towards a cure for RET-Positive NSCLC. SUBSCRIBE to C-Path's YouTube Channel Now ▻▻ FOLLOW C-Path: ... This engaging session will guide attendees through the

This engaging discussion from Critical Path Institute's (C-Path) Global Impact Conference (CGIC) One of the top topics at the World Economic Forum is generative AI, with endless discussions on how it can impact a broad range ... This presentation provided an overview of major deficiency trends in first assessment cycle of ANDAs. The presenter shared ... In this episode, we unpack the key insights from Forum Discussion 04 at the AD/PD™ This presentation introduced background information on artificial intelligence and machine learning in This presentation provided an overview of the pre-ANDA scientific meeting process related to topics that provide prospective ...

Representatives from biotech and pharma companies will provide Join us in Tirana, Albania, on the 15th and 16th of May

Photo Gallery

2025 Annual Drug Development Update with Dr Lawrence Korngut
FA Symposium 2025: Friedreich's Ataxia Drug Development Pipeline Update and Q&A (Session #7)
Session 2: Trial Designs for Combination Drug Development
2025 Annual Conference: Clinical Trials - Industry Updates
PPMD 2025 Annual Conference: Day 3 - How MRI is Advancing Drug Development for Duchenne
The AD Drug Development Pipeline: Observations and Implications, AD/PD™ Session Spotlight
WPC Research Spotlight - Drug development as a progression through stages
2025 Annual RET Research Update
INC Annual Meeting 2025: Future of Pediatric Neonatal Drug Development: Shared Strategy & Solutions
2025 RDDS Day 1 - Session 2: Navigating the Drug Development Roadmap - An Overview
C-Path Global Impact Conference 2025: Real-World Data for Drug Development
Novartis CEO discusses how AI will impact drug development
View Detailed Profile
2025 Annual Drug Development Update with Dr Lawrence Korngut

2025 Annual Drug Development Update with Dr Lawrence Korngut

Join us for the

FA Symposium 2025: Friedreich's Ataxia Drug Development Pipeline Update and Q&A (Session #7)

FA Symposium 2025: Friedreich's Ataxia Drug Development Pipeline Update and Q&A (Session #7)

Moderated by Jennifer Farmer, Chief Executive Officer, FARA Representatives from: Biogen, Design Therapeutics, Larimar ...

Sponsored
Session 2: Trial Designs for Combination Drug Development

Session 2: Trial Designs for Combination Drug Development

Friends of Cancer Research

2025 Annual Conference: Clinical Trials - Industry Updates

2025 Annual Conference: Clinical Trials - Industry Updates

2025

PPMD 2025 Annual Conference: Day 3 - How MRI is Advancing Drug Development for Duchenne

PPMD 2025 Annual Conference: Day 3 - How MRI is Advancing Drug Development for Duchenne

How MRI is Advancing

Sponsored
The AD Drug Development Pipeline: Observations and Implications, AD/PD™ Session Spotlight

The AD Drug Development Pipeline: Observations and Implications, AD/PD™ Session Spotlight

In this episode of AD/PD™ Session Spotlight, we present Plenary Lecture 1 from AD/PD™

WPC Research Spotlight - Drug development as a progression through stages

WPC Research Spotlight - Drug development as a progression through stages

Research Spotlight on Andrew Siderowf, MD, MS.

2025 Annual RET Research Update

2025 Annual RET Research Update

Progress towards a cure for RET-Positive NSCLC.

INC Annual Meeting 2025: Future of Pediatric Neonatal Drug Development: Shared Strategy & Solutions

INC Annual Meeting 2025: Future of Pediatric Neonatal Drug Development: Shared Strategy & Solutions

SUBSCRIBE to C-Path's YouTube Channel Now ▻▻ https://www.youtube.com/c/CriticalPathInstitute FOLLOW C-Path: ...

2025 RDDS Day 1 - Session 2: Navigating the Drug Development Roadmap - An Overview

2025 RDDS Day 1 - Session 2: Navigating the Drug Development Roadmap - An Overview

This engaging session will guide attendees through the

C-Path Global Impact Conference 2025: Real-World Data for Drug Development

C-Path Global Impact Conference 2025: Real-World Data for Drug Development

This engaging discussion from Critical Path Institute's (C-Path) Global Impact Conference (CGIC)

Novartis CEO discusses how AI will impact drug development

Novartis CEO discusses how AI will impact drug development

One of the top topics at the World Economic Forum is generative AI, with endless discussions on how it can impact a broad range ...

GDF2025 - D2S12- Common Quality Major Deficiencies in Abbreviated New Drug Applications (ANDAs)

GDF2025 - D2S12- Common Quality Major Deficiencies in Abbreviated New Drug Applications (ANDAs)

This presentation provided an overview of major deficiency trends in first assessment cycle of ANDAs. The presenter shared ...

Translational Drug Development in AD, AD/PD™ Session Spotlight

Translational Drug Development in AD, AD/PD™ Session Spotlight

In this episode, we unpack the key insights from Forum Discussion 04 at the AD/PD™

Building Bridges: From Discovery to Approval in Cancer Drug Development

Building Bridges: From Discovery to Approval in Cancer Drug Development

The

REdI 2024 | D2S05 - Artificial Intelligence/Machine Learning: The New Frontier of Drug Development..

REdI 2024 | D2S05 - Artificial Intelligence/Machine Learning: The New Frontier of Drug Development..

This presentation introduced background information on artificial intelligence and machine learning in

GDF2025 – D1S17 - Pre-Abbreviated New Drug Application (ANDA) Meetings: Process and Best Practices

GDF2025 – D1S17 - Pre-Abbreviated New Drug Application (ANDA) Meetings: Process and Best Practices

This presentation provided an overview of the pre-ANDA scientific meeting process related to topics that provide prospective ...

Session 1: Seamless Trial Designs for Rare Cancer Drug Development

Session 1: Seamless Trial Designs for Rare Cancer Drug Development

Friends of Cancer Research

Locana - Industry Updates On Drug Development (2018 MDF Annual Conference)

Locana - Industry Updates On Drug Development (2018 MDF Annual Conference)

Representatives from biotech and pharma companies will provide

OHD Events 2025

OHD Events 2025

Join us in Tirana, Albania, on the 15th and 16th of May

Related Video Content

Adventurous Ideas | Grants awarded information

2025: 80 000€ 2026: 50 000€ The Finnish Nature Association is an environmental organization for children and youth,...

Adventurous Ideas | Grants awarded information

Adventurous Ideas is a Helsinki-based pioneering evergreen investment and impact company with a deep-rooted passion...

Adventurous Ideas | Grants awarded information

2025: 50 000€ 2026: 50 000€ The broiler is the most common bird in Finland, yet it remains invisible in public...

Sponsored